Advertisement

Health


LuminaX Healthtech Accelerator accepts record cohort of founders for 2024

LuminaX Healthtech Accelerator accepts record cohort of founders for 2024

The Gold Coast’s LuminaX HealthTech Accelerator has accepted ...

Zea Relief gets a healthy boost to its retail footprint through Woolworths distribution deal

Zea Relief gets a healthy boost to its retail footprint through Woolworths distribution deal

Zea Relief, a Tasmanian wellness scale-up that has developed a rang...

AI medtech Artrya secures first Australian commercial agreement with The Cardiac Centre NSW

AI medtech Artrya secures first Australian commercial agreement with The Cardiac Centre NSW

Perth-based medtech Artrya (ASX: AYA) has secured the first commerc...

Australia’s biggest chemist is merging with a giant wholesaler. Could we soon be paying more?

Australia’s biggest chemist is merging with a giant wholesaler. Could we soon be paying more?

Corporate Australia loves a big merger. And amid a growing flurry o...

Genesis Capital lifts Pacific Smiles takeover bid to $279 million

Genesis Capital lifts Pacific Smiles takeover bid to $279 million

Pacific Smiles (ASX: PSQ) suitor Genesis Capital has brus...

Advertisement
Advertisement
Advertisement
FDA fast tracks Mesoblast COVID-19 treatment

FDA fast tracks Mesoblast COVID-19 treatment

A COVID-19 treatment being developed by Australian pharmaceutical...

Viva Leisure raises $30m to pump up as gym junkies return in droves

Viva Leisure raises $30m to pump up as gym junkies return in droves

As gym junkies return in droves to its centres, Viva Leisure (ASX: ...

Mesoblast, Novartis sign commercialisation deal for COVID-19 treatment

Mesoblast, Novartis sign commercialisation deal for COVID-19 treatment

Australian pharmaceutical company Mesoblast (ASX: MSB) has penned...

Pfizer COVID-19 vaccine now 95 per cent effective

Pfizer COVID-19 vaccine now 95 per cent effective

A COVID-19 vaccine candidate being developed by US pharmaceutical...

Althea gets green light to sell Australian-made medicinal cannabis in Germany

Althea gets green light to sell Australian-made medicinal cannabis in Germany

Melbourne-based Althea Group (ASX: AGH) is on track to becoming t...

Class action "the only hope" for Smiles Inclusive partners on the sidelines

Class action "the only hope" for Smiles Inclusive partners on the sidelines

Smiles Inclusive (ASX: SIL) joint venture partners (JVPs) have ha...

CSL to build $800m flu vaccine facility in Melbourne

CSL to build $800m flu vaccine facility in Melbourne

Australia-headquartered CSL (ASX: CSL) is set to bring a cell-bas...

UQ COVID-19 vaccine "ahead of schedule", Phase 3 trials to commence soon

UQ COVID-19 vaccine "ahead of schedule", Phase 3 trials to commence soon

A COVID-19 vaccine being developed by the University of Queenslan...

Restrictions on ACT venues to ease tomorrow, patron cap will increase to 500

Restrictions on ACT venues to ease tomorrow, patron cap will increase to 500

The improving COVID-19 situation in Victoria and New South Wales ...

Mesoblast rebounds on COVID-19 treatment update, puts vaccine concerns to bed

Mesoblast rebounds on COVID-19 treatment update, puts vaccine concerns to bed

Melbourne-based med-tech company Mesoblast (ASX: MSB) has rebound...

Health fund backs medicinal cannabis with Little Green Pharma deal

Health fund backs medicinal cannabis with Little Green Pharma deal

Little Green Pharma (ASX: LGP) hopes a new strategic partnership ...

Smiles Inclusive enters voluntary administration

Smiles Inclusive enters voluntary administration

The local anaesthetic of turnaround promises has finally wor...

MedAdvisor to buy USA's largest patient-prescriber network Adheris for $49m

MedAdvisor to buy USA's largest patient-prescriber network Adheris for $49m

Medical software group MedAdvisor (ASX: MDR) is prepared to ...

Healthia to buy The Optical Company for $43 million

Healthia to buy The Optical Company for $43 million

Just one day after announcing yet another spending spree, allied ...

Atomo's COVID-19 nasal swab test gets green light from TGA

Atomo's COVID-19 nasal swab test gets green light from TGA

Sydney-based Atomo Diagnostics (ASX: AT1) has yet another feather...

Advertisement

Partner Content

In today's fast-paced investment landscape, time is a valuable commo...
Private credit specialist Finexia Financial Group (ASX: FNX) has se...
After relocating his Canberra-founded company Whitefox Recruitment ...
Armed with a growing business and a great opportunity, a business o...
The digital revolution may have changed the office forever, but the...
Private credit specialist Finexia Financial Group (ASX: FNX) has ac...
Environmental engineer Romin Nejad began his career at Epic Environ...
The transition from elite athlete and gymnastics coach to a corpora...
Advertisement